COV — Toxotis Investments Public Income Statement
0.000.00%
Last trade - 00:00
FinancialsMicro Cap
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | Interim Report | ARS |
Standards: | IFRS | IFRS | IFRS | — | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.073 | 0.538 | 0.204 | -0.023 | 0.071 |
Selling / General / Administrative Expenses | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.157 | 0.201 | 0.096 | 0.3 | 0.102 |
Operating Profit | -0.084 | 0.338 | 0.107 | -0.323 | -0.032 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.094 | 0.325 | 0.046 | -0.43 | -0.151 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.11 | 0.23 | 0.041 | -0.409 | -0.151 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -0.11 | 0.23 | 0.041 | -0.409 | -0.151 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.11 | 0.23 | 0.041 | -0.409 | -0.151 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.005 | 0.011 | 0.002 | -0.02 | -0.007 |